Misuse of Drugs (Medicinal Cannabis) Amendment Regulations 2020

2020/261

Coat of Arms of New Zealand

Misuse of Drugs (Medicinal Cannabis) Amendment Regulations 2020

Patsy Reddy, Governor-General

Order in Council

At Wellington this 21st day of September 2020

Present:
The Right Hon Jacinda Ardern presiding in Council

These regulations are made under sections 37 and 37A of the Misuse of Drugs Act 1975

(a)

on the advice and with the consent of the Executive Council; and

(b)

on the recommendation and advice of the Minister of Health given in accordance with section 37A of the Misuse of Drugs Act 1975.

Regulations

1 Title

These regulations are the Misuse of Drugs (Medicinal Cannabis) Amendment Regulations 2020.

2 Commencement

These regulations come into force on 30 September 2020.

3 Principal regulations

These regulations amend the Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the principal regulations).

4 Schedule 1 amended

In Schedule 1, clause 1(2), replace “during the 6-month period that starts at the commencement of these regulations” with “until 1 April 2021”.

Michael Webster,
Clerk of the Executive Council.

Explanatory note

This note is not part of the regulations, but is intended to indicate their general effect.

These regulations, which come into force on 30 September 2020, amend the Misuse of Drugs (Medicinal Cannabis) Regulations 2019.

The amendment provides a 6-month extension to the transitional period during which there is an exemption to the minimum quality standard applying to the product of a licence holder. That transitional period now ends on 31 March 2021 and the minimum quality standard will apply on and after 1 April 2021.

Issued under the authority of the Legislation Act 2012.

Date of notification in Gazette: 24 September 2020.

These regulations are administered by the Ministry of Health.